Donoghue Forlines’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-15,014
| Closed | -$3.67M | – | 139 |
|
|
2026
Q1 | $3.67M | Sell |
15,014
-5,164
| -26% | -$1.2M | 1.02% | 17 |
|
|
2025
Q4 | $4.18M | Sell |
20,178
-638
| -3% | -$126K | 1.29% | 6 |
|
|
2025
Q3 | $3.86M | Buy |
20,816
+11,328
| +119% | +$1.94M | 1.19% | 8 |
|
|
2025
Q2 | $1.45M | Buy |
9,488
+554
| +6% | +$85.2K | 0.41% | 91 |
|
|
2025
Q1 | $1.48M | Buy |
+8,934
| New | +$1.4M | 0.47% | 81 |
|
|
2024
Q4 | – | Sell |
-15,753
| Closed | -$2.55M | – | 181 |
|
|
2024
Q3 | $2.55M | Buy |
15,753
+11,553
| +275% | +$1.84M | 0.73% | 25 |
|
|
2024
Q2 | $614K | Sell |
4,200
-7,882
| -65% | -$1.17M | 0.17% | 125 |
|
|
2024
Q1 | $1.91M | Buy |
12,082
+2,538
| +27% | +$404K | 0.54% | 37 |
|
|
2023
Q4 | $1.5M | Sell |
9,544
-856
| -8% | -$131K | 0.47% | 49 |
|
|
2023
Q3 | $1.62M | Buy |
10,400
+2,258
| +28% | +$373K | 0.58% | 31 |
|
|
2023
Q2 | $1.35M | Buy |
8,142
+1,649
| +25% | +$266K | 0.42% | 48 |
|
|
2023
Q1 | $1.01M | Sell |
6,493
-2,563
| -28% | -$414K | 0.36% | 82 |
|
|
2022
Q4 | $1.6M | Buy |
9,056
+1,738
| +24% | +$300K | 0.57% | 34 |
|
|
2022
Q3 | $1.2M | Sell |
7,318
-5,423
| -43% | -$918K | 0.43% | 22 |
|
|
2022
Q2 | $2.26M | Sell |
12,741
-892
| -7% | -$159K | 0.59% | 22 |
|
|
2022
Q1 | $2.42M | Sell |
13,633
-4,785
| -26% | -$814K | 0.52% | 32 |
|
|
2021
Q4 | $3.15M | Sell |
18,418
-313
| -2% | -$51.2K | 0.53% | 27 |
|
|
2021
Q3 | $3.02M | Buy |
18,731
+313
| +2% | +$53.4K | 0.59% | 27 |
|
|
2021
Q2 | $3.03M | Buy |
18,418
+1,706
| +10% | +$282K | 0.57% | 33 |
|
|
2021
Q1 | $2.75M | Buy |
16,712
+9,548
| +133% | +$1.54M | 0.53% | 37 |
|
|
2020
Q4 | $1.13M | Sell |
7,164
-860
| -11% | -$127K | 0.22% | 119 |
|
|
2020
Q3 | $1.2M | Buy |
+8,024
| New | +$1.19M | 0.33% | 83 |
|
|
2020
Q2 | – | Sell |
-5,684
| Closed | -$745K | – | 81 |
|
|
2020
Q1 | $745K | Sell |
5,684
-17,611
| -76% | -$2.5M | 0.17% | 32 |
|
|
2019
Q4 | $3.4M | Sell |
23,295
-10,221
| -30% | -$1.39M | 0.53% | 35 |
|
|
2019
Q3 | $4.34M | Sell |
33,516
-11,544
| -26% | -$1.52M | 0.62% | 43 |
|
|
2019
Q2 | $6.28M | Buy |
+45,060
| New | +$6.24M | 0.73% | 57 |
|
|
2017
Q4 | – | Sell |
-123,359
| Closed | -$16M | – | 134 |
|
|
2017
Q3 | $16M | Buy |
123,359
+1,505
| +1% | +$200K | 1.69% | 41 |
|
|
2017
Q2 | $16.1M | Buy |
+121,854
| New | +$15.5M | 1.83% | 23 |
|
Other funds holding JNJ
Donoghue Forlines's JNJ Position: Q2 2026 in Review
Donoghue Forlines sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 15,014 shares — an estimated $3.67M sold.
Donoghue Forlines first reported a position in JNJ in Q2 2017 and held it in 28 quarters. The position peaked at $16.1M in Q2 2017. 4,685 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Donoghue Forlines reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
- Donoghue Forlines sold 15,014 Johnson & Johnson shares in Q2 2026, an estimated $3.67M.
- Donoghue Forlines first reported a position in Johnson & Johnson in Q2 2017 and held it in 28 quarters.
- Donoghue Forlines's Johnson & Johnson position peaked at $16.1M in Q2 2017.
- 4,685 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Donoghue Forlines's 13F filing for Q2 2026, filed 7 Aug 2026.